Hiroshi Imamura

Active 1978–2024

Also published as
Hiroshi IMAMURA
124
Papers
19,849
Citations
78
h-index
108
i10-index

Citations

Citations per year for Hiroshi Imamura1978: 1 citations1980: 2 citations1983: 1 citations1984: 3 citations1985: 1 citations1986: 1 citations1988: 4 citations1989: 2 citations1990: 1 citations1991: 1 citations1994: 3 citations1996: 3 citations1997: 19 citations1998: 32 citations1999: 43 citations2000: 65 citations2001: 65 citations2002: 75 citations2003: 90 citations2004: 93 citations2005: 88 citations2006: 103 citations2007: 112 citations2008: 127 citations2009: 125 citations2010: 130 citations2011: 141 citations2012: 173 citations2013: 151 citations2014: 132 citations2015: 160 citations2016: 160 citations2017: 149 citations2018: 108 citations2019: 462 citations2020: 444 citations2021: 397 citations2022: 261 citations2023: 186 citations2024: 331 citations2025: 113 citations2026: 8 citations1979: no citations, so this year is not shown1981–1982: no citations, so these years are not shown1987: no citations, so this year is not shown1992–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,048 citing papers, 17.5% of this breakdownJapan: 1,037 citing papers, 17.4% of this breakdownChina: 831 citing papers, 13.9% of this breakdownItaly: 318 citing papers, 5.3% of this breakdownSouth Korea: 302 citing papers, 5.1% of this breakdownFrance: 300 citing papers, 5% of this breakdownUnited Kingdom: 259 citing papers, 4.3% of this breakdownGermany: 253 citing papers, 4.2% of this breakdownNetherlands: 146 citing papers, 2.5% of this breakdownSpain: 144 citing papers, 2.4% of this breakdownCanada: 126 citing papers, 2.1% of this breakdownSwitzerland: 111 citing papers, 1.9% of this breakdown
0%17.5%Other 18.4%

Fields

  • Medicine74.6%
  • Biochemistry, Genetics and Molecular Biology13.8%
  • Engineering3.1%
  • Physics and Astronomy2.6%
  • Computer Science2.3%
  • Neuroscience1.2%
  • Other2.4%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis11.4%
  • Gastric Cancer Management and Outcomes6.9%
  • Cholangiocarcinoma and Gallbladder Cancer Studies5.1%
  • Organ Transplantation Techniques and Outcomes4.4%
  • Liver Disease Diagnosis and Treatment3.2%
  • Liver Disease and Transplantation2.6%
  • Other66.4%

Coauthors

All papers

Open in search
  1. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

    Authors: , , , , , , , , , , - Journal of Hepatology 2003 cited by 1,575

  2. Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 2,520

  3. Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma

    Authors: , , , , , , , , , - Gastroenterology 2008 cited by 761

  4. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2014 cited by 533

  5. Spin dice: A scalable truly random number generator based on spintronics

    Authors: , , , , , , - Applied Physics Express 2014 cited by 231

  6. Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma

    Authors: , , , , , , , , , , , - Annals of Surgery 2016 cited by 329

  7. Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer

    Authors: , , , , , , , , , - British journal of surgery 2012 cited by 180

  8. Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial

    Authors: , , , , , , , , , , , , , , , , - Gastric Cancer 2021 cited by 68

  9. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer

    Authors: , , , , , , , , , , , - Gastric Cancer 2014 cited by 140

  10. Intraoperative Fluorescent Cholangiography Using Indocyanine Green: A Biliary Road Map for Safe Surgery

    Authors: , , , , , , , - Journal of the American College of Surgeons 2008 cited by 271

  11. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

    Authors: , , , , , , , , , , , - Journal of Gastroenterology 2010 cited by 188

  12. Effects of an Oral Elemental Nutritional Supplement on Post-gastrectomy Body Weight Loss in Gastric Cancer Patients: A Randomized Controlled Clinical Trial

    Authors: , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2016 cited by 105

  13. One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years

    Authors: - Archives of Surgery 2003 cited by 835

  14. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test

    Authors: , , , , - Journal of Hepato-Biliary-Pancreatic Surgery 2005 cited by 368

  15. Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

    Authors: , , , , , , , , , , , , , - British Journal of Cancer 2014 cited by 140

  16. Importance of respiratory rate for the prediction of clinical deterioration after emergency department discharge: a single‐center, case–control study

    Authors: , , , , , , , - Acute Medicine & Surgery 2016 cited by 95

  17. Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal Metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2023 cited by 19

  18. Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer

    Authors: , , , , , , , , , , - Clinical Cancer Research 2012 cited by 226

  19. Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastric Cancer 2020 cited by 76

  20. Long‐term effects of an oral elemental nutritional supplement on post‐gastrectomy body weight loss in gastric cancer patients (KSES002)

    Authors: , , , , , , , , , , , , , , - Annals of Gastroenterological Surgery 2019 cited by 54

  21. Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108)

    Authors: , , , , , , , , , , , , , , , , , - Annals of Gastroenterological Surgery 2021 cited by 24

  22. Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Gastric Cancer 2020 cited by 22

  23. Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma

    Authors: , , , , , , , , , - Annals of Surgery 2005 cited by 641

  24. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer

    Authors: , , , , , , , , , - British journal of surgery 2009 cited by 239